Blood transfusions and non-Hodgkin's lymphoma

Epidemiologic Reviews

Volumn 24, Issue 2, 2002, Pages 269-279

  Chow, Eric J ^a   Holly, Elizabeth A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW;

BLOOD TRANSFUSION; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 0038064142     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/epirev/mxf005     Document Type: Review

References (71)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992;52(suppl):5432s-40s.
3. Cartwright R, Brincker H, Carli PM, et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer 1999;35:627-33.
4. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000;88:2398-424.
5. Weidmann C, Black RJ, Masuyer E, et al. Incidence of non-Hodgkin's lymphoma in children between 1970 and 1990 in nine European countries. Eur J Cancer 1999;35:1235-7.
6. Groves FD, Linet MS, Travis LB, et al. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92:1240-51.
7. Parkin DM, Whelan SL, Ferlay J, et al, eds. Cancer incidence in five continents. Vol VII. Lyon, France: International Agency for Research on Cancer, 1997. (IARC Scientific Publication no. 143).
8. Kinlen L. Immunosuppressive therapy and acquired immunological disorders. Cancer Res 1992;52(suppl):5474s-6s.
9. Filipovich AH, Mathur A, Kamat D, et al. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992;52(suppl):5465s-7s.
10. Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992;52(suppl):5566s-9s.
11. Zahm SH, Blair A. Pesticides and non-Hodgkin's lymphoma. Cancer Res 1992;52(suppl):5485s-8s.
12. Pearce N, Bethwaite P. Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors. Cancer Res 1992;52(suppl):5496s-500s.
13. Holford TR, Zheng T, Mayne ST, et al. Time trends of non-Hodgkin's lymphoma: Are they real? What do they mean? Cancer Res 1992;52(suppl):5443s-6s.
14. Banks PM. Changes in diagnosis of non-Hodgkin's lymphomas over time. Cancer Res 1992;52(suppl):5453s-5s.
15. Holly EA, Lele C, Bracci PM, et al. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999;150:375-89.
16. Zhang S, Hunter DJ, Rosner BA, et al. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst 1999;91:1751-8.
17. Holly EA, Lele C, Bracci PM. Hair-color products and risk for non-Hodgkin's lymphoma: a population-based study in the San Francisco Bay Area. Am J Public Health 1998;88:1767-73.
18. Altekruse SF, Henley SJ, Thun MJ. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 1999;10:617-25.
19. Adami J, Gridley G, Nyrén O, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999;80:641-5.
20. Cerhan JR, Wallace RB, Folsom AR, et al. Transfusion history and cancer risk in older women. Ann Intern Med 1993;119:8-15.
21. Blomberg J, Möller T, Olsson H, et al. Cancer morbidity in blood recipients - results of a cohort study. Eur J Cancer 1993;29A:2101-5.
22. Memon A, Doll R. A search for unknown blood-borne oncogenic viruses. Int J Cancer 1994;58:366-8.
23. Brandt L, Brandt J, Olsson H, et al. Blood transfusion as a risk factor for non-Hodgkin lymphoma. Br J Cancer 1996;73:1148-51.
24. Adami J, Nyrén O, Bergström R, et al. Blood transfusion and non-Hodgkin lymphoma: lack of association. Ann Intern Med 1997;127:365-71.
25. Anderson H, Brandt L, Ericson A, et al. Blood transfusion at delivery and risk of subsequent malignant lymphoma in the mother. Vox Sang 1998;75:145-8.
26. Nelson RA, Levine AM, Bernstein L. Blood transfusions and the risk of intermediate- or high-grade non-Hodgkin's lymphoma. J Natl Cancer Inst 1998;90:1742-3.
27. Maguire-Boston EK, Suman V, Jacobsen SJ, et al. Blood transfusion and risk of non-Hodgkin's lymphoma. Am J Epidemiol 1999;149:1113-18.
28. Tavani A, Soler M, La Vecchia C, et al. Re: "Blood transfusions and the risk of intermediate- or high-grade non-Hodgkin's lymphoma." (Letter). J Natl Cancer Inst 1999;91:1332-3.
29. Chow EJ, Holly EA. Blood transfusion as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study. Am J Epidemiol 2002;155:725-31.
30. Surgenor DM, Wallace EL, Hao SH, et al. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990;322:1646-51.
31. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine (first of two parts): blood transfusion. N Engl J Med 1999;340:438-47.
32. Vamvakas EC, Taswell HF. Epidemiology of blood transfusion. Transfusion 1994;34:464-70.
33. Friedman BA, Burns TL, Schork MA. A study of blood utilization by diagnosis, month of transfusion, and geographic region of the United States. Transfusion 1979;19:511-25.
34. Cook SS, Epps J. Transfusion practice in central Virginia. Transfusion 1991;31:355-60.
35. Chiavetta JA, Herst R, Freedman J, et al. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996;36:699-706.
36. Zimmermann R, Büscher M, Linhardt C, et al. A survey of blood component use in a German university hospital. Transfusion 1997;37:1075-83.
37. Lyons SF, Liebowitz DN. The roles of human viruses in the pathogenesis of lymphoma. Semin Oncol 1998;25:461-75.
38. Catlin EA, Roberts JD, Erana R, et al. Transplacental transmission of natural-killer-cell lymphoma. N Engl J Med 1999;341:85-91.
39. Bodó I, Peters M, Radich JP, et al. Donor-derived acute promyelocytic leukemia in a liver-transplant recipient. N Engl J Med 1999;341:807-13.
40. Lee TH, Paglieroni T, Ohto H, et al. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999;93:3127-39.
41. Opelz G, Sengar DP, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-9.
42. Klein HG. Immunomodulatory aspects of transfusion. Anesthesiology 1999;91:861-5.
43. Landers DF, Hill GE, Wong KC, et al. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187-204.
44. Lane TA, Anderson KC, Goodnough LT, et al. Leukocyte reduction in blood component therapy. Ann Intern Med 1992;117:151-62.
45. Jensen LS. Benefits of leukocyte-reduced blood transfusions in surgical patients. Curr Opin Hematol 1998;5:376-80.
46. Blumberg N, Heal J. Renal allograft survival in transfused and non-transfused patients. (Letter). Lancet 1988;1:946.
47. Mynster T. Effects of red cell storage and lysis on in vitro cytokine release. Transfus Apheresis Sci 2001;25:17-23.
48. Kirkley SA, Cowles J, Pellegrini VD Jr, et al. Cytokine secretion after allogeneic or autologous blood transfusion. (Letter). Lancet 1995;345:527.
49. Dzik S. Mechanisms underlying the immunomodulatory effect of allogeneic blood transfusion. In: Anderson KC, Ness PM, eds. Scientific basis of transfusion medicine - implications for clinical practice. 2nd ed. Philadelphia, PA: WB Saunders Company, 2000:444-54.
50. Cerhan JR, Wallace RB, Folsom AR, et al. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 1997;89:314-18.
51. Cerhan JR, Wallace RB, Dick F, et al. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2001;10:361-8.
52. Nelson RA, Levine AM, Marks G, et al. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. Br J Cancer 1997;76:1532-7.
53. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
54. Gerard-Marchant R, Hamlin I, Lennert K, et al. Classification of non-Hodgkin's lymphomas. Lancet 1974;2:406-8.
55. Jaffe ES, Raffeld M, Medeiros LJ, et al. An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts. Cancer Res 1992;52(suppl):5447s-52s.
56. Hartge P, Brinton LA, Rosenthal JF, et al. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984;120:825-33.
57. Klecka WR, Tuchfarber AJ. Random-digit dialing: a comparison to personal surveys. Public Opin Q 1978;42:105-14.
58. Olson SH, Kelsey JL, Pearson TA, et al. Evaluation of random digit dialing as a method of control selection in case-control studies. Am J Epidemiol 1992;135:210-22.
59. Lele C, Holly EA, Roseman DS, et al. Comparison of control subjects recruited by random digit dialing and area survey. Am J Epidemiol 1994;140:643-8.
60. Phillips SJ, Whisnant JP, O'Fallon WM, et al. A community blood pressure survey: Rochester, Minnesota. Mayo Clinic Proc 1988;63:691-9.
61. Wacholder S, Silverman DT, McLaughlin JK, et al. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992;135:1029-41.
62. Herrinton LJ. Epidemiology of the Revised European-American Lymphoma classification subtypes. Epidemiol Rev 1998;20:187-203.
63. Folsom AR, Kaye SA, Prineas RJ, et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990;131:794-803.
64. Ragni MV, Belle SH, Jaffe RA, et al. Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood 1993;81:1889-97.
65. Greenwalt TJ. A short history of transfusion medicine. Transfusion 1997;37:550-63.
66. Cartwright RA, McKinney PA, O'Brien C, et al. Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire. Leuk Res 1988;12:81-8.
67. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992;52(suppl):5510s-5s.
68. Franceschi S, Dal Maso L, La Vecchia C. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer 1999;83:481-5.
69. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
70. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-18.
71. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88:15-19.